ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1834

Sleep Apnea and Fibromyalgia: Data from the Cleveland Clinic Fibromyalgia Registry

Carmen E. Gota1, Nilamba Jhala2, Sahar Kaouk3, Yaseen Kinanah4 and William Wilke5, 1Education, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, 2Internal Medicine, Cleveland Clinic, Cleveland, OH, 3John Carroll University, University Heights, OH, 4Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH, 5Orthopedic and Rheumatologic Institute, Cleveland Clinic, Cleveland, OH

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Fibromyalgia and sleep apnea

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, October 22, 2018

Title: 4M082 ACR Abstract: Fibromyalgia & Other Clinical Pain Syndromes (1834–1839)

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose:

Up to 50% of sleep apnea (SA) patients have fibromyalgia (FM). Little is known about the prevalence and associations of SA and FM, and the impact of continuous positive airway pressure (CPAP) use in patients with FM.

Methods:

Consecutive patients diagnosed with FM by clinical and/or ACR 2010 criteria, were enrolled and classified according to reported history of SA and CPAP use. Sleep characteristics and FM measures of severity, depression and function were compared between groups.

Results:

Characteristics of 667 FM patients were: age 45.9±37.6, 89.5% female, 79.9% white, BMI 30±8.7, Fibromyalgia impact questionnaire score 63.5±20.1, Epworth Sleepiness Scale 9.5±5.9, hours of sleep 6.1±2.0, 85.9% reported unrefreshing sleep, 65% trouble falling asleep, 73.7% trouble staying asleep. Prior diagnosis of SA was reported by 154 (21%) FM patients, of which 50 patients (32.4%) used CPAP, for 6.4±1.4 days/week. Comparisons between FM with SA and without, and between CPAP users and non users are presented in Table 1 and Table 2.

Table 1.

Comparison between FM patients with and without a prior history of sleep apnea.

No prior diagnosis of sleep apnea

N 513

Prior diagnosis of sleep apnea

N 154

p

Age

45.4 ±11.1

48.12±11.8

0.746

BMI

29±7.7

33.6±10.5

0.000

Hours of sleep/night

6.0±1.9

6.3±2.2

0.559

ESS

9.1±5.9

10.5±5.7

0.014

Patient health questionnaire -9 (PHQ-9)

12.2±6.1

11±6.94

0.006

Fibromyalgia impact questionnaire

(FIQ)

63.6±18.5

64.3±23.7

0.587

Health assessment questionnaire -disability index

(HAQ-DI)

1.0±1.46

1.2±1.1

0.411

Widespread pain index

(WPI)

12.1±9.0

12.4±4.4

0.905

Symptom severity scale

(SS)

8.8±2.3

9.3±2.4

0.021

Fibromyalgianess scale

(PSD)

21.1±10.0

22.1±5.4

0.559

Unrefreshing sleep

89.5%

N 459

86.4%

N 133

0.000

Trouble falling asleep

67.6%

N 347

65.6%

N 101

0.000

Trouble staying asleep

78%

N 400

75.3%

N 116

0.000

Table 2.

Comparison between FM patient with sleep apnea who used CPAP regularly with those who did not use CPAP

Not using CPAP

N 104

Using CPAP

N 50

p

Age

47.6±13.0

49.5±9.4

0.7

BMI

32.0±10.2

36.3±11.0

0.000

Hours of sleep/night

6.2±2.4

6.4±2.0

0.491

ESS

9.6±7.0

12.0±5.9

0.006

PHQ9

14.4±7.0

13.1±6.8

0.013

FIQ

63.5±23.9

65.9±24.0

0.405

HAQDI

1.2±1.3

1.2±1.1

0.487

WPI

12.0±4.5

12.8±4.3

0.812

SS

9.1±2.5

9.4±2.0

0.408

PSD

21.5±5.5

22.5±5.3

0.684

Unrefreshing sleep

88.7%

N 86

84.7%

N 42

0.259

Trouble falling asleep

71.5%

N 69

56%

N 29

0.215

Trouble staying asleep

82.5%

N 80

60%

N 30

0.033

Conclusion:

Quality of sleep was poor in FM; SA was reported by 1/5 FM patients, who had higher BMI, SS, and were more depressed; 1/3rd of FM SA patients used CPAP; compared to those who did not, CPAP users where more obese, had higher daytime sleepiness, were less depressed and had less trouble staying asleep. Longitudinal studies are needed to determine the true prevalence of sleep apnea in FM, confirm and understand the directionality of these observations.


Disclosure: C. E. Gota, None; N. Jhala, None; S. Kaouk, None; Y. Kinanah, None; W. Wilke, None.

To cite this abstract in AMA style:

Gota CE, Jhala N, Kaouk S, Kinanah Y, Wilke W. Sleep Apnea and Fibromyalgia: Data from the Cleveland Clinic Fibromyalgia Registry [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/sleep-apnea-and-fibromyalgia-data-from-the-cleveland-clinic-fibromyalgia-registry/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/sleep-apnea-and-fibromyalgia-data-from-the-cleveland-clinic-fibromyalgia-registry/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology